Copyright
©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Biol Chem. Mar 26, 2010; 1(3): 31-40
Published online Mar 26, 2010. doi: 10.4331/wjbc.v1.i3.31
Published online Mar 26, 2010. doi: 10.4331/wjbc.v1.i3.31
Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer
Shou Wei Han, Jesse Roman, Division of Pulmonary, Critical Care and Sleep Disorders Medicine, Department of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, United States
Jesse Roman, Louisville Veterans Affairs Medical Center, Louisville, KY, 40202, United States
Author contributions: Han SW wrote the paper; Roman J edited the paper.
Supported by The National Institutes of Health CA123104 (Han SW) and CA116812 (Roman J)
Correspondence to: Shou Wei Han, MD, PhD, Division of Pulmonary, Critical Care and Sleep Disorders Medicine, Department of Medicine, University of Louisville School of Medicine, CTR Building, Room 524, 505 Hancock St., Louisville, KY 40202, United States. sw.han@louisville.edu
Telephone: +1-505-8528468 Fax: +1-505-8526233
Received: March 17, 2010
Revised: March 23, 2010
Accepted: March 24, 2010
Published online: March 26, 2010
Revised: March 23, 2010
Accepted: March 24, 2010
Published online: March 26, 2010
Core Tip